IQVIA Holdings Inc. vs Johnson & Johnson
IQV vs JNJ — side-by-side comparison from reported financials. IQV leads 2, JNJ leads 8 of 10 comparable metrics.
IQVIA Holdings Inc.
IQV · Healthcare
$259.88+0.39%Strained
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | IQV | JNJ |
|---|---|---|
| Price | $259.88 | $261.79 |
| Market cap | $42.8B | $631B |
| Revenue (TTM) | $17.0B | $97.9B |
| Revenue growth | +4.2% | +5.6% |
| Net margin | 8.1% | 21.5% |
| Free cash flow | $2.18B | $22.2B |
| Net cash (debt) | ($11.7B) | ($27.8B) |
| 1-year price return | +28.0% | +37.0% |
| P/E | 31.1 | 29.9 |
| P/E vs own history (cheap-side %) | 56% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | 22% | 26% |
| Altman Z-score | 1.78 | — |
| CV checks passed | 8 of 10 | 10 of 10 |
| Employees | 94,000 | 140,800 |
Full résumé-style profiles: IQV CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.